Skip to search formSkip to main contentSkip to account menu

Molecular Risk Assessment

A procedure in which biomarkers (for example, biological molecules or changes in tumor cell DNA) are used to estimate a person's risk for developing… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
Loss of heterozygosity at 3p in benign lesions preceding invasive breast cancer.
BACKGROUND Loss of heterozygosity (LOH) at chromosome 3p is one of the most common genetic abnormalities identified in human… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)